首頁 > 市場調查報告書 > 醫療設備

整形外科

膝關節腫脹治療市場規模、佔有率及成長分析（按類型、藥物、手術、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1899242

膝關節腫脹治療市場規模、佔有率及成長分析（按類型、藥物、手術、最終用戶和地區分類）－2026-2033年產業預測

Swollen Knee Treatment Market Size, Share, and Growth Analysis, By Type (Medications, Patient-controlled Analgesia Pumps), By Medications (Opioids, Corticosteroids), By Surgery, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，膝關節腫脹治療市場規模將達到 21.8 億美元，到 2025 年將達到 22.8 億美元，到 2033 年將達到 32.5 億美元，在預測期（2026-2033 年）內，複合年成長率為 4.5%。

隨著患者越來越傾向非手術治療，膝關節腫脹治療市場正經歷一場變革。這一新興趨勢表明，患者越來越傾向於選擇治療和診斷程序而非傳統手術，凸顯了他們對微創和非侵入性治療方案的需求。人們對手術介入（尤其是關節重建手術）潛在併發症和副作用的認知不斷提高，推動了患者行為的轉變。隨著人們對手術治療風險的了解不斷加深，他們積極尋求能夠提供類似療效、同時最大限度減少創傷並縮短恢復期的替代方案。這種不斷變化的市場格局為符合患者對更安全、更微創治療偏好的創新治療方法提供了巨大的發展機會。

推動膝關節腫脹治療市場發展的因素

全球膝關節腫脹治療市場的主要促進因素之一是肥胖及相關肌肉骨骼疾病的增加。隨著肥胖率的上升，越來越多的人因關節壓力增加而出現膝關節問題，例如骨關節炎和損傷。不斷擴大的患者群體需要有效的治療方案，從而推動了對膝關節腫脹的專業治療方法、藥物和復健服務的需求。此外，人們對關節健康意識的提高以及對早期療育重要性的認知不斷增強，也促進了膝關節腫脹治療市場的成長，這主要源於患者希望減輕不適並改善活動能力。

膝關節腫脹治療市場的限制因素

全球膝關節腫脹治療市場的主要限制因素之一是先進治療方法和手術干預的高成本。許多患者面臨經濟障礙，難以獲得有效的治療，尤其是在醫療體系欠缺發展的地區。某些手術缺乏保險覆蓋進一步加劇了這一經濟困境，導致治療延誤，並擴大了醫療資源分配不均的現象。此外，價格低廉的家庭療法和非處方藥的普及也可能使患者不願尋求專業的醫療服務，從而影響膝關節腫脹治療市場的整體成長潛力。

膝蓋腫脹治療市場趨勢

膝關節腫脹治療市場正經歷顯著的變革，這主要得益於醫療設備技術的快速發展，以及整形外科治療水準的不斷提高。創新治療方法，尤其是膝關節矯正器具、支撐裝置和矯正植入，透過提升患者的舒適度和治療效果，正在重塑市場格局。這些器械能夠應對各種膝關節疾病，從急性損傷到慢性病，提供針對性的支撐、穩定性和矯正。隨著治療方法日益專業化和靈活化，醫療專業人員能夠根據每位患者的個別需求量身定做治療方案。治療選擇的多樣化正在推動市場成長，並在整形外科治療中發揮越來越重要的作用。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Stryker Corporation（USA）
Ossur（Iceland）
Smith & Nephew（United Kingdom）
Zimmer Biomet（USA）
Arthrex（USA）
DJO Global（USA）
Medacta International（Switzerland）
B. Braun Melsungen（Germany）
Exactech（USA）
Wright Medical Group（USA）
Corin Group（United Kingdom）
MicroPort Orthopedics（China）
Aesculap Implant Systems（Germany）
Tornier NV（Netherlands）
Bioventus（USA）
Pfizer（USA）
Novartis（Switzerland）

結論與建議

簡介目錄

Product Code: SQMIG35A2820

Swollen Knee Treatment Market size was valued at USD 2.18 Billion in 2024 and is poised to grow from USD 2.28 Billion in 2025 to USD 3.25 Billion by 2033, growing at a CAGR of 4.5% during the forecast period (2026-2033).

The market for swollen knee treatment is witnessing a transformative shift as patients increasingly favor non-surgical healthcare approaches. This emerging trend emphasizes the growing preference for therapeutic and propaedeutic techniques over conventional surgical procedures, highlighting a desire for minimally invasive and non-invasive options. Heightened awareness of the potential complications and side effects linked to surgical interventions, particularly knee arthroplasty, is driving this change in patient behavior. As individuals become more knowledgeable about the risks associated with surgical treatments, they are actively seeking alternative solutions that provide similar effectiveness while minimizing invasiveness and shortening recovery periods. This evolving landscape suggests a significant opportunity for innovative treatments that align with patients' preferences for safer, less invasive care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Swollen Knee Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Swollen Knee Treatment Market Segments Analysis

Global Swollen Knee Treatment Market is segmented by Type, Medications, Surgery, End User and region. Based on Type, the market is segmented into Medications, Patient-controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery. Based on Medications, the market is segmented into Opioids, Corticosteroids and Others. Based on Surgery, the market is segmented into Arthrocentesis, Arthroscopy and Knee Replacement. Based on End User, the market is segmented into Hospitals, Designated Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Swollen Knee Treatment Market

One of the key market drivers for the global swollen knee treatment market is the increasing prevalence of obesity and related musculoskeletal disorders. As obesity rates continue to rise, more individuals are experiencing knee-related issues due to the added stress on joints, leading to conditions such as osteoarthritis and injury. This growing patient population necessitates effective treatment options, driving demand for therapies, medications, and rehabilitation services tailored to knee swelling. Additionally, heightened awareness of joint health and the importance of early intervention further contribute to the expansion of the swollen knee treatment market, as patients seek to alleviate discomfort and improve mobility.

Restraints in the Swollen Knee Treatment Market

One key market restraint for the global swollen knee treatment market is the high cost of advanced therapeutic options and surgical interventions. Many patients face financial barriers that limit their access to effective treatments, particularly in regions with less developed healthcare systems. This economic constraint is further compounded by a lack of insurance coverage for certain procedures, leading to delayed treatment and increased healthcare inequalities. Additionally, the availability of alternative, less expensive home remedies and over-the-counter medications may deter patients from seeking professional medical care, thereby affecting the overall growth potential of the swollen knee treatment market.

Market Trends of the Swollen Knee Treatment Market

The Swollen Knee Treatment market is witnessing a pronounced shift driven by the rapid advancements in medical device technology that enhance orthopedic care. Innovative treatments, particularly in knee braces, supports, and orthotic implants, are reshaping the landscape by offering improved patient comfort and outcomes. These devices cater to a wide range of knee-related conditions, from acute injuries to chronic ailments, by providing targeted support, stability, and alignment. As treatments become more specialized and adaptable, healthcare professionals can customize their approaches to meet the distinct needs of patients. This diversification of therapeutic options is fostering growth within the market, making it increasingly pivotal in orthopedic healthcare.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Swollen Knee Treatment Market Size by Type & CAGR (2026-2033)

Market Overview
Medications
Patient-controlled Analgesia Pumps
Nerve Blocks
Liposomal Bupivacaine
Surgery

Global Swollen Knee Treatment Market Size by Medications & CAGR (2026-2033)

Market Overview
Opioids
Corticosteroids
Others

Global Swollen Knee Treatment Market Size by Surgery & CAGR (2026-2033)

Market Overview
Arthrocentesis
Arthroscopy
Knee Replacement
- Total Knee Replacement
- Unicompartmental Knee Replacement
- Others

Global Swollen Knee Treatment Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Designated Clinics
Ambulatory Surgical Centers
Others

Global Swollen Knee Treatment Market Size & CAGR (2026-2033)

North America (Type, Medications, Surgery, End User)
- US
- Canada
Europe (Type, Medications, Surgery, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Medications, Surgery, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Medications, Surgery, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Medications, Surgery, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Stryker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ossur (Iceland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arthrex (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DJO Global (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medacta International (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Exactech (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wright Medical Group (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corin Group (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Orthopedics (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aesculap Implant Systems (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tornier N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioventus (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments